News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 2008
- Sources here
- 18
- Companies here
- 24
Search results
Stored financial headlines
Active search
2008 matching headlines
Ticker or company: LABMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Q3 EPS Estimates for Shattuck Labs Raised by HC Wainwright
HC Wainwright has raised its Q3 2026 EPS estimate for Shattuck Labs (NASDAQ:STTK) to a loss of $0.09 per share, an improvement from the previous estimate of a $0.21 loss. The firm maintained a "Buy" rating and a $14 price target, while the overall …
STTK
main company
Sharemaestro market context
Trend signal active
52 weeks +672.9%
Rocket Lab Corporation Announces Dollar-for-Dollar Replacement At-The-Market Equity Program
Rocket Lab Corporation has announced a replacement "at the market" (ATM) equity program, allowing it to offer and sell shares worth up to $1,944,369,826. This new agreement supersedes a previous one and does not increase the total offering amount. The company intends to use …
RKLB
main company
Sharemaestro market context
Price below Trend Line
52 weeks +80.8% · Next-week setup positive 55.7%
Proposed Rocket Lab-Iridium Deal Clears Antitrust Wait
Rocket Lab has achieved several key milestones in its proposed acquisition of Iridium Communications, including the expiration of the U.S. Hart-Scott-Rodino antitrust waiting period and the filing of a Form S-4 registration statement with the SEC. The companies also submitted FCC applications for license …
RKLB
main company
Sharemaestro market context
Price below Trend Line
52 weeks +80.8% · Next-week setup positive 55.7%
Rocket Lab May Use Share-Sale Proceeds for Iridium Deal, Debt
Rocket Lab (Nasdaq: RKLB) has announced a new at-the-market (ATM) equity distribution agreement, replacing a previous one, allowing it to offer and sell common stock valued at up to $1.94 billion. The proceeds from these sales are intended to help fund the cash portion …
RKLB
main company
Sharemaestro market context
Price below Trend Line
52 weeks +80.8% · Next-week setup positive 55.7%
Rocket Lab Corporation Announces Progress on Iridium Acquisition: HSR Period Lapses; Form S-4 Filed; FCC Applications Filed; Capital Strategy Underway
Rocket Lab Corporation LONG BEACH, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced substantial milestones in connection with its previously announced proposed acquisition of …
RKLB
main company
Sharemaestro market context
Price below Trend Line
52 weeks +80.8% · Next-week setup positive 55.7%
Silicon Labs (SLAB) Stock Looks Above Fair Value After A 67% Run
Silicon Laboratories (SLAB) stock has seen a 67.3% return over the last year, but current valuations suggest it may be above fair value. Trading at a P/S ratio of 8.8x, higher than the industry average, the stock screens as overvalued. While recent revenue and …
SLAB
main company
Sharemaestro market context
Trend signal active
52 weeks +50.5%
Wasatch Advisors LP Increases Position in Mesa Laboratories, Inc. $MLAB
Wasatch Advisors LP significantly increased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 125.8% in the second quarter, now owning 115,668 shares valued at $11.5 million. This comes as other institutional investors also adjusted their positions in the medical instruments supplier. Despite an overall …
MLAB
main company
Sharemaestro market context
Trend signal active
52 weeks +46.4%
V. M. Manning & CO. Inc. Acquires New Position in Abbott Laboratories $ABT
V. M. Manning & CO. Inc. has acquired a new stake in Abbott Laboratories, purchasing 19,849 shares valued at approximately $1.8 million, making it their 11th largest holding. This move comes as Abbott Laboratories exceeded its quarterly earnings expectations and maintains a positive outlook …
ABT
main company
Sharemaestro market context
Price above Trend Line
52 weeks -14.8% · Next-week setup positive 55.5%
Proto Labs, Inc. $PRLB Position Raised by Quantinno Capital Management LP
Quantinno Capital Management LP significantly increased its stake in Proto Labs, Inc. (NYSE:PRLB) by 98.9% in the first quarter, now owning 27,716 shares valued at $1.58 million. This comes as Proto Labs reported strong quarterly earnings, beating analyst estimates with an EPS of $0.60 …
PRLB
main company
Sharemaestro market context
Trend signal active
52 weeks +81.2%
214,546 Shares in BioAge Labs, Inc. $BIOA Purchased by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP acquired a new position in BioAge Labs, Inc. (NASDAQ:BIOA), purchasing 214,546 shares valued at approximately $3.75 million, representing a 0.48% stake in the company. Other institutional investors like Geode Capital and Marshall Wace also increased their holdings. Despite reporting a …
BIOA
main company
Sharemaestro market context
Price below Trend Line
52 weeks +129.9% · Next-week setup positive 65.7%
Astera Labs, Inc. (NASDAQ:ALAB) Given Average Recommendation of "Moderate Buy" by Analysts
Analysts have issued a "Moderate Buy" rating for Astera Labs (NASDAQ:ALAB), with 13 buy recommendations and 10 hold ratings, and an average 12-month price target of $325.25. The company demonstrated strong operating momentum, with revenue up 104.5% year-over-year and EPS exceeding estimates, driven by …
ALAB
main company
Sharemaestro market context
Trend signal active
52 weeks +79.6% · Next-week setup positive 59.8%
Dr. Reddy's Laboratories advances Thursday, outperforms competitors
Shares of Dr. Reddy's Laboratories Ltd. (500124) increased by 0.59% to 1,206.00 Indian rupees on Thursday. This occurred during a positive trading session for the stock market, with the BSE SENSEX Index (1) rising by 0.15%. The company's shares closed 14.73% below their 52-week …
RDY
main company
Sharemaestro market context
Price below Trend Line
52 weeks -15.4%
Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares
Representative Mike Kelly sold shares of Abbott Laboratories (NYSE:ABT) valued between $1,001 and $15,000 on July 17th, as well as shares of PepsiCo and Walt Disney on the same day. This sale occurred despite Abbott Laboratories reporting a quarterly earnings beat and reaffirming its …
ABT
main company
Sharemaestro market context
Price above Trend Line
52 weeks -14.8% · Next-week setup positive 55.5%
Bio Rad Laboratories (BIO) Issues Flat Revenue Guidance, Is It Too Far Above Fair Value?
Bio-Rad Laboratories (BIO) has seen a sharp increase in its stock price over the last 90 days, despite recent flat revenue guidance and a significant long-term decline in shareholder return. The company is currently trading above its fair value estimate of $293, driven by …
Sharemaestro market context Trend signal active 52 weeks +17.3%ZLAB - Expanding China Healthcare And Global Pipelines Will Broaden Patient Options
Zai Lab's fair value has been adjusted slightly lower to $33.30, yet the company is broadening patient options through expanding its China healthcare presence and global pipelines. Key developments include regulatory approvals for TIVDAK in China, Orphan Drug Designation for zocilurtatug pelitecan in Europe, …
ZLAB
main company
Sharemaestro market context
Trend signal active
52 weeks -26.1%